van der Heijden Claudia A J, Aerts Luca, Chaldoupi Sevasti-Marisevi, van Cruchten Cas, Kawczynski Michal, Heuts Samuel, Bidar Elham, Luermans Justin G L M, Maesen Bart
Department of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Ann Cardiothorac Surg. 2024 Jan 30;13(1):54-70. doi: 10.21037/acs-2023-afm-0129. Epub 2023 Dec 13.
In this state-of-the art review on hybrid atrial fibrillation (AF) ablation, we briefly focus on the pathophysiology of AF, the rationale for the hybrid approach, its technical aspects and the efficacy and safety outcomes after hybrid AF ablation, both from meta-analyses and randomized control trial data. Also, we performed a systematic search to provide a provisional overview of real-world hybrid AF ablation efficacy and safety outcomes. Furthermore, we give an insight into the 'Maastricht approach', an approach that allows us to tailor the ablation procedure to the individual patient. Finally, we reflect on future perspectives with the objective to continue improving our thoracoscopic hybrid AF ablation approach. Based on the review of the available literature, we believe it is fair to state that thoracoscopic hybrid AF ablation is a valid alternative to catheter ablation for the treatment of patients with more persistent forms of AF.
在这篇关于混合式心房颤动（AF）消融的前沿综述中，我们简要聚焦于AF的病理生理学、混合式方法的原理、其技术层面以及混合式AF消融后的疗效和安全性结果，这些结果均来自荟萃分析和随机对照试验数据。此外，我们进行了系统检索，以提供真实世界中混合式AF消融疗效和安全性结果的初步概述。再者，我们深入探讨了“马斯特里赫特方法”，这是一种能让我们根据个体患者情况定制消融手术的方法。最后，我们思考未来的前景，目标是持续改进我们的胸腔镜下混合式AF消融方法。基于对现有文献的综述，我们认为可以合理地说，胸腔镜下混合式AF消融是治疗更持续性AF患者的一种有效的导管消融替代方法。
